Danial, Abdurahman H.

HRN: 21-29-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/03/2022
05/09/2022
IV
1.5 G
Q6H
Furunculosis
Waiting Final Action 
05/03/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/03/2022
05/09/2022
IV
300 Mg
Q6H
Furunculosis
Waiting Final Action 
05/05/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/05/2022
05/11/2022
TOPICAL
Topical
BID
Decubitus Ulcer
Waiting Final Action 
05/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/10/2022
05/16/2022
IV
300mg
Q6
Multiple Skin Abscess
Waiting Final Action 
05/11/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/11/2022
05/17/2022
TOPICAL
Ample Amount
Bid
Furonculosis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: